An open-label, multi-centre, post-marketing study to assess the efficacy and safety of a plasma-derived VWF/FVIII concentrate in patients with von Willebrand disease

Affiliations

• ¹ Haemophilia Centre, Medical Clinic II, Institute of Transfusion Medicine, Goethe University Hospital, Frankfurt am Main, Germany.
• ² Coagulation Research Center, Duisburg, Germany.
• ³ "Aghia Sophia" Children's Hospital, Athens, Greece.
• ⁴ Department of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University of Wroclaw, Wroclaw, Poland.
• ⁵ Department of Haematology, University Hospital, Jagiellonian University Medical College, Cracow, Poland.
• ⁶ Department of Pediatrics, Institute of Medical Sciences, Medical College, University of Rzeszow, Rzeszow, Poland.
• ⁷ Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, UK.
• ⁸ St George's Healthcare NHS Trust Haemophilia Centre, London, UK.
• ⁹ Imperial College, London, UK and Imperial College Healthcare NHS Trust, London, UK.
• ¹⁰ Children's Haemophilia Centre, Evelina London Children's Hospital, London, UK.
• ¹¹ CSL Behring, Marburg, Germany.
• ¹² Medical University of Vienna, Vienna, Austria.